MMP9 and experimental autoimmune encephalomyelitis: Therefore, similarly to what was observed in experimental autoimmune encephalomyelitis, our data suggest that loss of MMP-2 activity in hepatic IRI exacerbated disease, in part, by augmenting MMP-9 secretion.